SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
+11.78%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.79B
AUM Growth
+$2.79B
(+14%)
Cap. Flow
+$64.9M
Cap. Flow
% of AUM
2.33%
Top 10 Holdings %
Top 10 Hldgs %
40.95%
Holding
113
New
14
Increased
21
Reduced
19
Closed
15
Top Buys
| 1 |
Benitec Biopharma
BNTC
|
$65.6M |
| 2 |
Starbucks
SBUX
|
$53.6M |
| 3 |
Capital One
COF
|
$35.3M |
| 4 |
CrowdStrike
CRWD
|
$34.3M |
| 5 |
BIOA
BioAge Labs, Inc. Common Stock
BIOA
|
$30.3M |
Top Sells
| 1 |
Arcellx
ACLX
|
$69M |
| 2 |
Insmed
INSM
|
$64.7M |
| 3 |
Ultragenyx Pharmaceutical
RARE
|
$50.6M |
| 4 |
Elevance Health
ELV
|
$49.5M |
| 5 |
Sysco
SYY
|
$37.2M |
Sector Composition
| 1 | Healthcare | 59.5% |
| 2 | Technology | 11.2% |
| 3 | Consumer Discretionary | 8.56% |
| 4 | Communication Services | 7.2% |
| 5 | Financials | 5.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Five Below
FIVE
$8.33B
| – | – |
-7,645
| Closed | -$833K |
|
102
Gilead Sciences
GILD
$140B
| – | – |
-50,700
| Closed | -$3.48M |
|
103
Immatics
IMTX
$662M
| – | – |
-946,563
| Closed | -$11M |
|
104
Humana
HUM
$37.5B
| – | – |
-1,950
| Closed | -$729K |
|
105
Intel
INTC
$105B
| – | – |
0
| – | – |
|
|
MREO
106
Mereo BioPharma
MREO
$275M
| – | – |
-75,000
| Closed | -$270K |
|
107
Morgan Stanley
MS
$237B
| – | – |
-4,611
| Closed | -$448K |
|
108
Protagonist Therapeutics
PTGX
$3.62B
| – | – |
-30,500
| Closed | -$1.06M |
|
109
SPDR S&P 500 ETF Trust
SPY
$656B
| – | – |
0
| – | – |
|
110
Spyre Therapeutics
SYRE
$1.02B
| – | – |
-107,310
| Closed | -$2.52M |
|
|
111
Sysco
SYY
$38.8B
| – | – |
-520,900
| Closed | -$37.2M |
|
112
Tourmaline Bio
TRML
$645M
| – | – |
-125,000
| Closed | -$1.61M |
|
|
RVNC
113
DELISTED
Revance Therapeutics, Inc.
RVNC
| – | – |
-58,425
| Closed | -$150K |
|